Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells
Authors:
Open Access
- 27 January 2014
- journal article
- Published by Wiley in Cancer Science
- Vol. 105 (2) , 186-194
Abstract
Tumor angiogenesis contributes to inferior prognosis in osteosarcoma. Apurinic/apyrimidinic endonuclease 1 (APE1) and fibroblast growth factor 2 (FGF2) and its receptor 3 (FGFR3) signaling pathway plays an important role in the angiogenic process. In this study we observed that high expression of APE1, FGF2 and FGFR3, and microvessel density are positively correlated with poor prognosis of osteosarcoma patients. Furthermore, the Cox model showed that the tumor size, FGF2 and its receptor 3 (FGFR3), and microvessel density were adverse prognostic factors. Based on our clinical data, and the fact that APE1 is involved in tumor angiogenesis, we hypothesize that it is very likely that APE1 may indirectly promote angiogenesis by upregulating fibroblast FGF2 and FGFR3. Our preliminary data show small interfering RNA‐mediated silence of APE1 experiments, which further supports this hypothesis. APE1‐small interfering RNA significantly inhibited tumor angiogenesis by downregulatingin vitroexpression of FGF2 and FGFR3 in human umbilical vein endothelial cells in Matrigel tube formation assay, and further inhibited tumor growthin vivoin a mouse xenograft model. Thus, the proposed APE1‐FGF2 and FGFR3 pathway may provide a novel mechanism for regulation of FGF2 and FGFR3 by APE1 in tumor angiogenesis.Keywords
Funding Information
- National Natural Science Foundation of China (30872975)
This publication has 37 references indexed in Scilit:
- MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growthCancer Letters, 2013
- APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposureToxicology, 2013
- Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft ModelPLOS ONE, 2013
- Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcomaBiochemical Pharmacology, 2013
- Base excision repair and cancerCancer Letters, 2012
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma XenograftsMolecular Cancer Therapeutics, 2012
- The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 AntagonistMolecular Cancer Therapeutics, 2012
- The angiome: a new concept in cancer biologyJournal of Clinical Pathology, 2011
- Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivoVision Research, 2011
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008